MedTrace Logo

The Effects of Laughter Therapy on Hemodialysis on Depression

NCT04098627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2019-10-03

No results posted yet for this study

Summary

End stage kidney disease is associated with increased depression. Laughter is associated with improvement in depression in chronic disease. The study objective was to measure the effect of intradialytic group laughter therapy on anxiety and depression. Pragmatic randomized controlled trial conducted in 10 hemodialysis centers in Northern California. The intervention group received a once weekly 30-minute long group laughter therapy session for 8 weeks. Primary outcome was depression score as measured using the Patient Health Questionnaire.

Conditions

Interventions

BEHAVIORAL

Laughter Therapy

Once weekly 30-minute long group laughter therapy session for 8 weeks

Sponsors & Collaborators

  • Satellite Healthcare

    lead OTHER

Principal Investigators

  • Paul N Bennett, PhD · Satellite Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-05-07
Completion
2019-03-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04098627 on ClinicalTrials.gov